Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

A. L. Ho; N. Chau; J. Bauman; K. Bible; A. Chintakuntlawar; M. E. Cabanillas; D. J. Wong; I. Braña Garcia; M. S. Brose; V. Boni; C. Even; M. Razaq; V. Mishra; K. Bracken; D. Wages; C. Scholz; A. Gualberto

doi:10.1093/annonc/mdy287.002

Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

A. L. Ho, N. Chau, J. Bauman, K. Bible, A. Chintakuntlawar, M. E. Cabanillas, D. J. Wong, I. Braña Garcia, M. S. Brose, V. Boni, C. Even, M. Razaq, V. Mishra, K. Bracken, D. Wages, C. Scholz, A. Gualberto

Endocrine Neoplasia & HD

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	viii373
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy287.002
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy287.002

Cite this

Ho, A. L., Chau, N., Bauman, J., Bible, K., Chintakuntlawar, A., Cabanillas, M. E., Wong, D. J., Braña Garcia, I., Brose, M. S., Boni, V., Even, C., Razaq, M., Mishra, V., Bracken, K., Wages, D., Scholz, C., & Gualberto, A. (2018). Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii373. https://doi.org/10.1093/annonc/mdy287.002

Ho, AL, Chau, N, Bauman, J, Bible, K, Chintakuntlawar, A, Cabanillas, ME, Wong, DJ, Braña Garcia, I, Brose, MS, Boni, V, Even, C, Razaq, M, Mishra, V, Bracken, K, Wages, D, Scholz, C & Gualberto, A 2018, 'Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii373. https://doi.org/10.1093/annonc/mdy287.002

@article{fd35d47a0c1245d08e33d6def3cb63ee,

title = "Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations",

author = "Ho, {A. L.} and N. Chau and J. Bauman and K. Bible and A. Chintakuntlawar and Cabanillas, {M. E.} and Wong, {D. J.} and {Bra{\~n}a Garcia}, I. and Brose, {M. S.} and V. Boni and C. Even and M. Razaq and V. Mishra and K. Bracken and D. Wages and C. Scholz and A. Gualberto",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy287.002",

language = "English (US)",

volume = "29",

pages = "viii373",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

AU - Ho, A. L.

AU - Chau, N.

AU - Bauman, J.

AU - Bible, K.

AU - Chintakuntlawar, A.

AU - Cabanillas, M. E.

AU - Wong, D. J.

AU - Braña Garcia, I.

AU - Brose, M. S.

AU - Boni, V.

AU - Even, C.

AU - Razaq, M.

AU - Mishra, V.

AU - Bracken, K.

AU - Wages, D.

AU - Scholz, C.

AU - Gualberto, A.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85063346234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063346234&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy287.002

DO - 10.1093/annonc/mdy287.002

M3 - Article

C2 - 32136908

SN - 0923-7534

VL - 29

SP - viii373

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this